Clinical trial NCT01500694 - References

Attention Deficit Hyperactivity Disorder (ADHD) — Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Citation(s)

•   Huss M, Dirks B, Gu J, Robertson B, Newcorn JH, Ramos-Quiroga JA
  Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1283-1294. doi: 10.1007/s00787-018-1113-4.

A Phase 3, Open-label, Multicentre Study to Provide Access to Guanfacine Hydrochloride Extended-release for European Subjects With Attention-deficit/Hyperactivity Disorder (ADHD) Who Participated in Study SPD503-315 or SPD503-316

Details for clinical trial NCT01500694